G. Daniele, M. Di Maio, and M. Piccirillo, “Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer: methodological comment:  ”, CBN, vol. 2, no. 1, pp. 35–37, Apr. 2014.